Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders

Published:2017-12 Issue: Volume:141 Page:657-675
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Farag Ahmed Karam,Elkamhawy Ahmed,Londhe Ashwini M.,Lee Kyung-Tae,Pae Ae Nim,Roh Eun Joo^ORCID

Funder

Creative Fusion Research Program

National Research Council of Science & Technology

KIST Institutional programs

Korea Institute of Science and Technology

Korea government (MSIP)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference53 articles.

1. Targeting signal transduction as a strategy to treat inflammatory diseases;O'Neill;Nat. Rev. Drug Discov.,2006

2. Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis;Dancevic;Arthritis Res. Ther.,2014

3. Oncogenic kinase signalling;Blume-Jensen;Nature,2001

4. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes;Choudhary;Mol. Cell,2009

5. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases;Patterson;Clin. Exp. Immunol.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining bioinformatics, network pharmacology, and artificial intelligence to predict the mechanism of resveratrol in the treatment of rheumatoid arthritis;Heliyon;2024-09

2. A novel μ₃-CO₃ bridged linear polymeric Cu-complex ([Cu₃(DMAP)₈(μ₃-CO₃)₂]I₂)_n·xH₂O: synthesis, characterization and catalytic applications in the synthesis of phenoxypyrimidines and arylthiopyrimidines via C–O and C–S cross-coupling reactions;RSC Advances;2024

3. Targeting colony‐stimulating factor 1 receptor: From therapeutic drugs to diagnostic radiotracers;iRADIOLOGY;2023-12-07

4. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment;European Journal of Medicinal Chemistry;2023-01

5. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach;Heliyon;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3